Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Jun 16, 2025; 17(6): 104539
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104539
Published online Jun 16, 2025. doi: 10.4253/wjge.v17.i6.104539
Table 1 Demographics, clinical features, and tumor characteristics of patients
Variable | Frequency (No.) | Percentage (%) |
Total | 14 | 100.00 |
Age, mean ± SD | 52.0 ± 14.0 (range 34-74) | |
Gender | ||
Male | 10 | 71.40 |
Female | 4 | 28.60 |
Clinical presentations | ||
Abdominal pain | 11 | 78.60 |
Weight loss | 12 | 85.70 |
Jaundice | 2 | 14.30 |
Generalized weakness | 1 | 7.10 |
Dyspepsia | 1 | 7.10 |
Size of lesion, mean ± SD | 4.5 ± 2.4 (range 0.4-9.8) | |
Duration from symptom onset to disease diagnosis, weeks | 4 (range 2-8) | |
Metastatic type of tumor | ||
Yes | 8 | 57.10 |
No | 6 | 42.90 |
- Citation: Ayesha S, Karim MM, Shahid AH, Rehman AU, Uddin Z, Abid S. Diagnostic role of endoscopic ultrasonography in defining the clinical features and histopathological spectrum of gastroenteropancreatic neuroendocrine tumors. World J Gastrointest Endosc 2025; 17(6): 104539
- URL: https://www.wjgnet.com/1948-5190/full/v17/i6/104539.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i6.104539